Shattuck Labs to Present Complete Dose-Escalation Data from
- SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent...
Stay updated with breaking news from Nasdaq Sttk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent...
Shattuck Labs, Inc. (NASDAQ:STTK – Get Rating) – Analysts at HC Wainwright upped their Q2 2023 EPS estimates for Shattuck Labs in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of ($0.52) for the quarter, up […]
Needham & Company LLC restated their buy rating on shares of Shattuck Labs (NASDAQ:STTK – Get Rating) in a research report report published on Thursday, Benzinga reports. Needham & Company LLC currently has a $14.00 price target on the stock. STTK has been the topic of a number of other research reports. HC Wainwright reaffirmed […]
HC Wainwright reaffirmed their buy rating on shares of Shattuck Labs (NASDAQ:STTK – Get Rating) in a research note released on Thursday morning, Benzinga reports. HC Wainwright currently has a $28.00 target price on the stock. STTK has been the subject of several other research reports. Needham & Company LLC reduced their price objective on […]
Needham & Company LLC restated their buy rating on shares of Shattuck Labs (NASDAQ:STTK – Get Rating) in a research report released on Thursday morning, Benzinga reports. Needham & Company LLC currently has a $14.00 target price on the stock. Other research analysts also recently issued reports about the company. HC Wainwright reaffirmed a buy […]